中药复方新药研发中质量标准研究需关注的问题

Problems in quality standard research of new traditional Chinese medicine compound

中药复方新药是中药新药研究的主体,体现中医药理论特色。复方新药质量标准研究是药学研究的主要内容之一,也是新药药学评价的重点内容。尽管近年来中药复方新药的研究水平有了较大提高,但笔者在审评过程中发现复方新药质量标准研究资料中仍然存在一些共性问题,该文通过分析目前中药复方新药质量标准研究资料中存在的问题,分别从含量测定指标的选择、含量范围的确定、质量标准设计理念等方面阐述了研发者需关注的问题。中药复方新药的质量不是仅质量标准本身就可以解决的,但质量标准是保证产品质量的关键环节和重要内容,产品质量的提高离不开质量标准的提高。随着科学技术的不断发展,在基于质量源于设计的理念指导下,中药复方新药质量标准系将日臻科学、系统和完善。

The new traditional Chinese medicine compound is the main part of the research of new drug of traditional Chinese medicine （TCM）, and the new Chinese herbal compound reflects the characteristics of TCM theory. The new traditional Chinese medicine compound quality standard research is one of the main content of pharmaceutical research, and is also the focus of the new medicine pharmaceutical evaluation content. Although in recent years the research level of new traditional Chinese medicine compound has been greatly improved, but the author during the review found still some common problems existing in new traditional Chinese medicine compound quality standard research data, this paper analyzed the current quality standards for new traditional Chinese medicine compound and the problems existing in the research data, respectively from measurement of the content of index selection, determine the scope of the content, and the quality standard design concept, the paper expounds developers need to concern. The quality of new traditional Chinese medicine compound quality standard is not only itself can be solved, but quality standards is to ensure the key and important content of product quality, improving the quality of products cannot do without quality standards. With the development of science and technology, on the basis of quality by design under the guidance of the concept, new traditional Chinese medicine compound quality standard system will be more scientific, systematic and perfect.